Quanticate Demonstrates New Outsourcing Strategy and Helpdesk at DIA 2011
Quanticate announces its new Centralized Clinical Data Sciences, an outsourcing strategy at this year’s 47th Annual DIA (Drug Information Association) Meeting, occurring in Chicago from June 19-23.
“Based on Quanticate’s 10-plus years of outsourcing and extensive clinical trial experience, this is an advancement in outsourcing that Quanticate is well placed to deliver. It has benefits in trial design and provides an efficient use of database design. Our outsourcing model can also leverage the latest technologies in cloud computing as well as ensure global regulatory compliance,” said David Underwood, CEO of Quanticate.
Centralized Clinical Data Sciences further develops strategic alliances and functional service provision and allows for easy combining of data from different studies within and across Phases.
In addition to the new outsourcing model, Quanticate is launching a Statistical Consultancy Helpdesk, an online resource that will provide easy access to expert Statistical Consultancy. Either via a dedicated phone line or the Internet, customers will be able to access the helpdesk with ease.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
